1 Min Read
Oct 25 (Reuters) - Genscript Biotech Corp
* Kanglitai informed by CFDA of approval on clinical trial; approved to commence clinical studies of KLT-1101 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.